eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
9.85
-0.14 (-1.40%)
Aug 15, 2025, 9:38 AM - Market open
eXoZymes Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
31
Market Cap
82.62M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | 70.07K | 41.47K | 145.01% |
Dec 31, 2022 | 28.60K | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEXOZ News
- 2 days ago - eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today - Accesswire
- 7 days ago - eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST - Accesswire
- 17 days ago - eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity - Accesswire
- 23 days ago - eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months - Accesswire
- 7 weeks ago - eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing - Accesswire
- 3 months ago - eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast - Accesswire
- 3 months ago - eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today - Accesswire
- 3 months ago - eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST - Accesswire